OWLSTONE MEDICAL
LIVE

Serial Number

79335641

Owner

Owlstone Medical Limited

Attorney

Feng Shan

Filing Date

Nov 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

OWLSTONE MEDICAL Trademark

Serial Number: 79335641 • Registration: 6841630

OWLSTONE MEDICAL is a trademark filed by Owlstone Medical Limited on November 24, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Owlstone Medical Limited (15 trademarks)

183 Cambridge Science Park,

Entity Type: 99

Trademark Details

Filing Date

November 24, 2021

Registration Date

September 13, 2022

Published for Opposition

June 28, 2022

Goods & Services

Scientific and technological services, namely, scientific research in the field of medical technology; Design and development of computer hardware and software; Design and development of computer hardware and software for medical and clinical use; Medical research services; Clinical research in the field of disease biomarkers; Chemical analysis; Chemical research; Analytical scientific and medical laboratory services in the field of disease biomarkers; Biological analysis; Laboratory analysis in the field of disease biomarkers; Scientific laboratory services; Laboratory testing services, namely, testing for disease biomarkers within gas, liquid, and solid samples for scientific research purposes; Medical laboratory services; Computer programming; Product design and development in the field of medical technology; Product research and development services relating to medical apparatus and instruments; Providing advice, information, and consultancy relating to the aforesaid services

Computer hardware and peripheral devices; Downloadable and recorded computer software and computer programs for collection and analyzing of medical samples in connection with and as part of medical apparatus and instruments; Downloadable and recorded computer application software for hand-held computing devices for analyzing medical samples in connection with and as part of medical apparatus and instruments; Downloadable and recorded computer software for analyzing medical samples in connection with and as part of medical apparatus and instruments; Downloadable and recorded clinical computer software for storing and analyzing data in database systems featuring patient medical information; Downloadable and recorded medical diagnostic software for collection and analyzing of medical samples in connection with and as part of medical apparatus and instruments; Downloadable and recorded computer operating system software; Data processing equipment; Electronic devices for storing, recording, transmitting, and reproducing information, data, or images, namely, computer hardware and laptops; Diagnostic apparatus for detection of disease bio-markers for laboratory or research use, not for medical purposes; Testing apparatus, not for medical purposes, for use to test calibration of spectrometers and gas detectors; Chemical detection systems and apparatus, namely, portable detection and identification instruments using gas detectors for detecting and identifying chemical substances, not for medical purposes; Particle detectors; Spectrometers; Pressure sensors; Downloadable and recorded computer software and computer programs for medical purposes for use to diagnose and monitor diseases in connection with and as part of medical apparatus and instruments; Structural and replacement parts and fittings for all the aforesaid

Medical apparatus and instruments for treating cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, and fatty liver disease; Medical diagnostic apparatus for detecting cancer cells; Chemical detection systems and apparatus for medical purposes, namely, portable detection and identification medical apparatus using gas detectors for detecting and identifying cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, and fatty liver disease; Medical imaging apparatus; Medical devices used for the collection, recording and analysis of volatile organic compounds in human breath; Medical testing kits for home use comprised of a medical device for detection of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, and fatty liver disease; Medical apparatus for the treatment of respiratory conditions; Medical diagnostic apparatus in the nature of breath detectors for testing for disease biomarkers for medical purposes; Spectrometers for medical purposes; Respiratory sensors, for medical purposes

Medical services; Consulting services relating to health care; Health care; Providing advice and information in the field of health; Medical care; Medical clinic services; Health clinic services; Medical health assessment services; Health screening services in the fields of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, and fatty liver disease; Diagnostic health screening services in the fields of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, and fatty liver disease; Providing medical information to medical professionals in the form of reports in the fields of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, and fatty liver disease; Medical testing for diagnostic or treatment purposes; Medical testing and analysis services for diagnostic purposes; Medical testing for disease biomarkers for diagnostic or treatment purposes; Providing advice, information, and consultancy services relating to the aforesaid

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 1, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 21, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 20, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2022 FICR
CORRECTION SENT TO IB
Dec 7, 2022 CRSN
CORRECTION CREATED FOR IB
Dec 6, 2022 CRCR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
REFUSAL PROCESSED BY IB
May 31, 2022 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
May 24, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 24, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 24, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 24, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 24, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 18, 2022 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 6, 2022 RFCS
REFUSAL PROCESSED BY MPU
May 6, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 23, 2022 RFCR
NON-FINAL ACTION WRITTEN
Apr 22, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 22, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 10, 2022 REPR